Vaccine News and Research

Latest Vaccine News and Research

People with egg allergy can have H1N1 flu vaccine in graded doses

As flu season got underway this fall, Dr. Catherine Monteleone, an allergist, noticed that her office started to receive an unusually high number of calls from people with egg allergy. They previously had avoided flu vaccines because of their sensitivity to eggs. This year, with all the attention being paid to the novel H1N1 influenza, those patients want to be protected against flu, and they contacted her to find out if they are candidates for inoculation.

19 Nov 2009

WHO to launch yellow fever vaccination campaign in West Africa

The WHO on Tuesday announced it would lead a week-long, multi-country vaccination campaign in Africa next week to protect those "deemed at highest risk from yellow fever," Reuters reports.

19 Nov 2009

GAVI Alliance drives down pentavalent vaccine costs, data shows

The "co-ordinated buying policy" of the GAVI Alliance has driven down "[t]he price of a vaccine that helps babies fight off killer diseases," according to data released by the group, Reuters reports. In 2010, the price of pentavalent vaccine, which protects against Hib (Haemophilus influenzae type b), diphtheria, whooping cough, tetanus and hepatitis B, will fall "below $3.0 - a drop of almost $0.50 cents per dose on the 2009 price," according to the news services.

19 Nov 2009

Tips for lessening needle anxiety

Experts believe fear of needles may be preventing people from rolling up their sleeves for the H1N1 vaccination.

18 Nov 2009

mdBriefCase to provide online education course on H1N1 virus in pregnant women

mdBriefCase Inc., in collaboration with the Public Health Agency of Canada (PHAC) and the Society of Obstetrics and Gynecology of Canada (SOGC), is pleased to provide a new online education course on the H1N1 virus in pregnant women.

18 Nov 2009

U.S. health officials testify before Senate Committee about H1N1 vaccine campaign

U.S. health officials defended their handling of the country's H1N1 (swine flu) vaccine campaign Tuesday "against criticism that their plan to protect Americans was confusing and over-optimistic," Reuters reports (Fox, 11/17).

18 Nov 2009

CEL-SCI commences clinical study of LEAPS-H1N1 treatment for hospitalized patients

CEL-SCI Corporation, a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases and a late-stage oncology company, announced today the start of the Company's first clinical study for hospitalized H1N1 patients at The Johns Hopkins University School of Medicine (Johns Hopkins).

18 Nov 2009

Sinovac Biotech receives a revised production license for its Panflu.1 vaccine

Sinovac Biotech Ltd., a leading developer and provider of vaccines in China, announced today that it received a revised production license from State Food and Drug Administration for Panflu.1, the Company's H1N1 vaccine. The population has been expanded to include people over 60 years old. The shelf life for PANFLU.1 was extended to one year from six months.

18 Nov 2009

SynCon Chikungunya virus DNA vaccine induces protective neutralizing antibody responses in animal model

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that the company's SynCon™ Chikungunya virus DNA vaccine induced protective neutralizing antibody responses in a preclinical non-human primate model.

18 Nov 2009

The Center for Modeling Optimal Outcomes discovers causal path of autism

During its research into the application of neuroscience in business, a New Jersey based think tank, The Center for Modeling Optimal Outcomes®, LLC (The Center) made an inadvertent and amazing discovery.

18 Nov 2009

Pentavalent price drops: the GAVI effect

Following the increasing impact of the GAVI Alliance on the vaccine market, the price of one of the major combination vaccines, the pentavalent, is falling considerably, enabling GAVI’s partners to vaccinate millions of more children in the developing world.

18 Nov 2009

Request for pre-IND meeting to discuss IND application for therapeutic vaccine granted by FDA

GeoVax Labs, Inc. (the "Company"), an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced that the U.S. Food and Drug Administration (FDA) has granted its request for a pre-IND meeting to discuss the proposed Investigational New Drug (IND) application for GeoVax's therapeutic vaccine as a treatment for individuals already infected with HIV.

18 Nov 2009

Ambrisentan improves health and exercise capacity of PAH patients, find researchers

In one of the few studies of the long-term effects of medication in the treatment of pulmonary arterial hypertension (PAH) disease, a team of researchers found the health and exercise capacity of PAH patients improved after two years of treatment with ambrisentan, according to a study published in the current edition of the Journal of the American College of Cardiology.

18 Nov 2009

Regulatory agencies offer marketing approval for new products to treat neglected diseases

New products to treat neglected diseases have received marketing approval from regulatory agencies at a steadily increasing rate in recent years as R&D funding for those diseases has increased, according to a recently completed study by the Tufts Center for the Study of Drug Development.

18 Nov 2009

Previous flu infections can reduce the severity of H1N1

Researchers at the La Jolla Institute for Allergy & Immunology have found that previous influenza infections may provide at least some level of immunity to the H1N1 "swine" flu. "The question we asked was, "Is the swine flu more like the seasonal flu or like a totally new strain of influenza where there would be no immunity?," said Alessandro Sette, Ph.D., an internationally recognized vaccine expert and director of the La Jolla Institute's Center for Infectious Disease.

18 Nov 2009

Cinergy Health creates a guide for the prevention and treatment of H1N1

Cinergy Health, a nationwide provider of guaranteed issue health insurance benefit programs, has created a guide for consumers concerned about the H1N1 virus, which has already killed more than 4,000 Americans.

18 Nov 2009

China, WHO to collaborate on flu research center

Chinese and WHO officials last week agreed to open a flu research center in Beijing, Bloomberg reports. "The new collaborating center for reference and research on influenza will join a network of WHO-affiliated labs in Atlanta, London, Tokyo and Melbourne that monitor flu strains and make recommendations on vaccines to fight the virus," the news service writes

17 Nov 2009

Also in global health news: Global corruption; HIV vaccine; smoking; DRC aid

A new report from Transparency International says the fight against corruption worldwide is slowing as urgency to address the global economic downturn recedes, Bloomberg reports.

17 Nov 2009

Bavarian Nordic awarded a new contract for developing a freeze-dried version of its IMVAMUNE smallpox vaccine

Bavarian Nordic A/S announced today that BARDA (Biomedical Advanced Research and Development Authority) has awarded a new contract to Bavarian Nordic for the development of a freeze-dried version of its IMVAMUNE(R) smallpox vaccine with a total prospective value of USD 40 million.

17 Nov 2009

Total of 1,686,100 doses of H1N1 vaccine allocated to Pennsylvania to date: Department of Health

The federal Centers for Disease Control and Prevention, or CDC, has allocated a total of 1,686,100 doses of H1N1 vaccine to Pennsylvania to date, the Department of Health said today.

17 Nov 2009

Vaccine News and Research

Latest Vaccine News and Research

People with egg allergy can have H1N1 flu vaccine in graded doses

WHO to launch yellow fever vaccination campaign in West Africa

GAVI Alliance drives down pentavalent vaccine costs, data shows

Tips for lessening needle anxiety

mdBriefCase to provide online education course on H1N1 virus in pregnant women

U.S. health officials testify before Senate Committee about H1N1 vaccine campaign

CEL-SCI commences clinical study of LEAPS-H1N1 treatment for hospitalized patients

Sinovac Biotech receives a revised production license for its Panflu.1 vaccine

SynCon Chikungunya virus DNA vaccine induces protective neutralizing antibody responses in animal model

The Center for Modeling Optimal Outcomes discovers causal path of autism

Pentavalent price drops: the GAVI effect

Request for pre-IND meeting to discuss IND application for therapeutic vaccine granted by FDA

Ambrisentan improves health and exercise capacity of PAH patients, find researchers

Regulatory agencies offer marketing approval for new products to treat neglected diseases

Previous flu infections can reduce the severity of H1N1

Cinergy Health creates a guide for the prevention and treatment of H1N1

China, WHO to collaborate on flu research center

Also in global health news: Global corruption; HIV vaccine; smoking; DRC aid

Bavarian Nordic awarded a new contract for developing a freeze-dried version of its IMVAMUNE smallpox vaccine

Total of 1,686,100 doses of H1N1 vaccine allocated to Pennsylvania to date: Department of Health

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Vaccine News and Research

Latest Vaccine News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in